Novartis, Lilly, and Bristol Myers Reportedly Eyeing Clinical-Stage Cancer Play

Major pharmaceutical companies Novartis, Eli Lilly, and Bristol Myers Squibb are reportedly showing interest in a clinical-stage cancer therapy, indicating potential future acquisitions or partnerships in the oncology space.